Han Zhong-Min, Huang He-Mei, Sun Yong-Wu
Department of Medical Technology, Zhengzhou Railway Vocational and Technical College, Zhengzhou, Henan 450052, P.R. China.
Oncol Lett. 2018 Aug;16(2):1622-1626. doi: 10.3892/ol.2018.8835. Epub 2018 May 30.
Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM-1) is the major antigen of the CD66 cluster of granulocyte differentiation antigens. The present study aimed to assess the biological function of CEACAM-1 on the growth of human colorectal cancer (CRC) cells . Treatment of cultured CRC HCT-8 cells with CEACAM-1-specific siRNA successfully downregulated CEACAM-1 expression by 61% compared with control cells. The effects of CEACAM-1 downregulation on HCT-8 cell proliferation and apoptosis were then assessed via Cell Counting kit-8 assay and flow cytometry, respectively. The results demonstrated that siRNA-induced CEACAM-1 downregulation significantly inhibited proliferation and increased apoptosis, but had no significant effect on cell cycle progression in HCT-8 cells. Together, these results suggest that CEACAM-1 activity is critical to CRC growth, and thus, CEACAM-1 may be a promising therapeutic target for the treatment of CRC.
癌胚抗原相关细胞粘附分子1(CEACAM-1)是粒细胞分化抗原CD66簇的主要抗原。本研究旨在评估CEACAM-1对人结肠直肠癌(CRC)细胞生长的生物学功能。用CEACAM-1特异性siRNA处理培养的CRC HCT-8细胞,与对照细胞相比,成功将CEACAM-1表达下调了61%。然后分别通过细胞计数试剂盒-8检测和流式细胞术评估CEACAM-1下调对HCT-8细胞增殖和凋亡的影响。结果表明,siRNA诱导的CEACAM-1下调显著抑制增殖并增加凋亡,但对HCT-8细胞的细胞周期进程没有显著影响。总之,这些结果表明CEACAM-1活性对CRC生长至关重要,因此,CEACAM-1可能是治疗CRC的一个有前景的治疗靶点。